Therapeutic Action
Cardiotonic
Source page 118
Loading InternPractice…
Individual generic drug information
Extracted information for DIGOXIN only.
Cardiotonic
Source page 118
Supraventricular arrhythmias (fibrillation, flutter, paroxysmal tachycardia) Heart failure
Source page 118
Extracted information for DIGOXIN only.
Do not administer to patients with bradycardia, ill defined arrhythmia, coronary artery disease. It is essential to monitor heart rate in the initial stage of treatment. May cause in the event of overdose: gastrointestinal disturbances (nausea, vomiting, diarrhoea), blurred vision, headache, confusion, conduction and rhythm disorders. If so, reduce dose or stop treatment. Do not combine with calcium, particularly by IV route (serious arrhythmias). Monitor combination with: amiodarone, macrolides, itraconazole, quinine, chloroquine (increased digoxin concentration); potassium-depleting drugs: diuretics, corticosteroids, amphotericin B (increased risk of digoxin toxicity). Monitor if possible serum potassium level in patients taking potassium-depleting drugs and serum creatinine level in patients with renal impairment. Do not administer simultaneously with antacids such as aluminium hydroxide, etc., administer 2 hours apart. Pregnancy: no contra-indication Breast-feeding: no contra-indication
Source pages 118, 119
Extracted information for DIGOXIN only.
250 micrograms (0.25 mg) tablet
Source page 118
Adult: 125 to 250 micrograms (0.125 to 0.25 mg) once daily Reduce the dose by half in older patients and in patients with renal impairment.
Source page 118
According to clinical response
Source page 118
Extracted information for DIGOXIN only.
– Below 25 °C
Source page 119
Filter the extracted dose blocks for this individual drug.
125 to 250 micrograms (0.125 to 0.25 mg) once daily
Candidate age grouping · source page 118